PepGen (PEPG) Change in Cash (2021 - 2026)
PepGen (PEPG) posted Change in Cash of -$18.4 million for Q1 2026, up 77.68% sequentially from -$82.3 million in Q4 2025, and down 217.28% YoY from $15.7 million in Q1 2025.
PepGen (PEPG) Change in Cash (2021 - 2026) Analysis & Trends
PepGen has reported Change in Cash for 6 years, with the latest figure at -$18.4 million in Q1 2026.
- Quarterly Change in Cash fell 217.28% year-over-year to -$18.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (up 98.36% YoY) and the FY2025 annual result came in at $11.1 million, up 135.38% from the prior year.
- Change in Cash grew to -$18.4 million in Q1 2026 per PEPG's latest filing, from -$82.3 million in the prior quarter.
- Over five years, Change in Cash peaked at $107.7 million in Q3 2025 and troughed at -$82.3 million in Q4 2025.
- A 5-year average of -$5.3 million and a median of -$16.3 million in 2023 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2025: Change in Cash surged 934.92% in 2022, then sank 1253.41% in 2025.
- Over 5 years, Change in Cash stood at -$14.0 million in 2022, then tumbled by 247.54% to -$48.8 million in 2023, then jumped by 114.63% to $7.1 million in 2024, then tumbled by 1253.41% to -$82.3 million in 2025, then jumped by 77.68% to -$18.4 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$18.4 million, -$82.3 million, and $107.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | PepGen | 207.09 Mn | 207.09 Mn | - | -19.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19.39 Mn |
| Mar 31, 2026 | -18.36 Mn |
| Dec 31, 2025 | -82.26 Mn |
| Sep 30, 2025 | 107.70 Mn |
| Jun 30, 2025 | -8.56 Mn |
| Mar 31, 2025 | -5.79 Mn |
| Dec 31, 2024 | 7.13 Mn |
| Sep 30, 2024 | -23.80 Mn |
| Jun 30, 2024 | -67.77 Mn |
| Mar 31, 2024 | 53.08 Mn |
| Dec 31, 2023 | -48.76 Mn |
| Sep 30, 2023 | -17.49 Mn |
| Jun 30, 2023 | -18.30 Mn |
| Mar 31, 2023 | -16.35 Mn |
| Dec 31, 2022 | -14.03 Mn |
| Sep 30, 2022 | -23.03 Mn |
| Jun 30, 2022 | 99.96 Mn |
| Mar 31, 2022 | -14.04 Mn |
| Dec 31, 2021 | -7.17 Mn |
| Sep 30, 2021 | 125.22 Mn |